Table 1

Sociodemographic characteristics, sexual behaviours, STI history and prevalent STIs for pre-exposure prophylaxis (PrEP) users in the l’Actuel PrEP Cohort (2013–2020)

Reported chemsexNo chemsex reportedTotal
Total50715792086
Median follow-up time (months)6.55.85.9
Total follow-up time (person-years)37011071477
Age (median, IQR)33(28–43)36(29–46)36(29–45)
Gender identity (n, %)
 Cis men50399.2%157699.8%207999.7%
 Trans men10.2%20.1%30.1%
 Trans women30.6%10.1%40.2%
Sexual orientation (n, %)
 Homosexual48395.3%148293.9%196594.2%
 Bisexual214.1%925.8%1135.4%
 Heterosexual20.4%30.2%50.2%
 Other00.0%10.1%10.1%
Missing 1 0.2% 1 0.1% 2 0.1%
Education (n, %)
 Primary51.0%90.6%140.7%
 Secondary7013.8%1459.2%21510.3%
 CEGEP11322.3%20312.9%31615.2%
 University25550.3%80050.7%105550.6%
Missing 64 12.6% 422 26.7% 486 23.3%
Annual income (n, %)
 ≤$C10 000305.9%895.6%1195.7%
 $C10 001–$$C20 000479.3%1157.3%1627.8%
 $C20 001–$C35 0007314.4%1418.9%21410.3%
 $C35 001–$C55 00012023.7%29818.9%41820.0%
 $C55 001–$C75 0009618.9%23114.6%32715.7%
 ≥$C75 00010019.7%36823.3%46822.4%
Missing 41 8.1% 337 21.3% 378 18.1%
Intravenous drug use in P12M (n, %)
 Yes51.0%70.4%120.6%
Missing 131 25.8% 539 34.1% 670 32.1%
Year of baseline consultation (n, %)
 201381.6%161.0%241.2%
 2014295.7%493.1%783.7%
 201511923.5%25416.1%37317.9%
 201614628.8%33221.0%47822.9%
 201710220.1%31119.7%41319.8%
 20186913.6%30719.4%37618.0%
 2019285.5%25015.8%27813.3%
 202061.2%603.8%663.2%
Number of regular partners in P12M
 Median (IQR)2(1–3)2(1–3)2(1–3)
Missing (n, %) 78 15.4% 422 26.7% 500 24.0%
Number of occasional partners in P12M
 Median (IQR)15(6–30)10(5–20)10(5–20)
Missing (n, %) 57 11.2% 403 25.5% 460 22.1%
Condom use in P12M (insertive anal sex) (n, %)*
 0%–25%9021.0%16213.8%25215.7%
 >25%–50%7517.5%14312.2%21813.6%
 >50%–75%4711.0%806.8%1277.9%
 >75%–100%17641.0%59450.6%77048.1%
Missing 41 9.6% 194 16.5% 235 14.7%
Condom use in P12M (receptive anal sex) (n, %)*
 0%–25%6415.3%979.1%16110.8%
 >25%–50%4310.3%868.1%1298.7%
 >50%–75%378.8%555.2%926.2%
 >75%–100%12128.9%45943.1%58039.1%
Missing 154 36.8% 368 34.6% 522 35.2%
Previous PEP use (n, %)
 Yes19338.1%49731.5%69033.1%
Missing 26 5.1% 285 18.% 311 14.9%
Self-reported STI history, ever (n, %)
 Gonorrhoea29157.4%61739.1%90843.5%
 Chlamydia24949.1%48630.8%73535.2%
 Syphilis11723.1%24015.2%35717.1%
 Hepatitis C virus61.2%100.6%160.8%
Missing 17 3.4% 170 10.8% 187 9.0%
Prevalent STI diagnoses—NAAT (n, %)
 Gonorrhoea7815.4%1408.8%21810.4%
 Chlamydia448.7%1167.3%1607.7%
Missing 36 7.1% 141 8.9% 177 8.5%
Seroprevalence (n, %)
 Hepatitis C virus20.4%20.1%40.2%
Missing 73 14.4% 310 19.7% 383 18.4%
  • Created by the authors.

  • CEGEP is Québec’s system of post-secondary education which offers pre-university and professional degrees.

  • *For condom use variables, the denominator was only clients who reported either insertive or receptive anal sex, hence the numbers here may not add up to the total in the first row.

  • CEGEP, Collège d'enseignement général et professionnel; NAAT, nucleic acid amplification test; PEP, post-exposure prophylaxis; P12M, past 12 months.